BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 10, Issue 1
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review
©The Author(s) 2020.
World J Transplant. Jan 18, 2020; 10(1): 1-14
Published online Jan 18, 2020. doi: 10.5500/wjt.v10.i1.1
Table 1 Major categories of ex vivo machine perfusion therapeutics in liver transplantation
CategoryAgents
RNAi pathwaysiRNA
Anti-sense oligonucleotide (Miravirsen)
Defatting cocktailVariable
VasodilatorsProstacyclin
BQ123 and Verapamil
Prostaglandin E1
OthersAnti-inflammatory agents
Human liver stem cells extracellular vesicles
δ-opioid agonist (Enkephalin)
NLRP3 inflammasome inhibitor mcc950
RNAi: Ribonucleic acid interference; siRNA: Small interfering ribonucleic acid; NLRP3: Nucleotide-binding domain leucine-rich repeat containing family pyrin domain containing 3.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.